The latest update of “Global Sarcopenia Treatment Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Sarcopenia Treatment Market.
Overview of the Sarcopenia Treatment Market:
The phenotype of sarcopenia is complex, with genetic and environmental factors all playing a role. While the specific causes and progression of sarcopenia remain largely unclear, there is an association between sarcopenia and a high risk of fall accidents. The severity of the condition is also highly dependent on comorbid conditions such as diabetes and hypertension. The primary cause of sarcopenia is aging.
Growing incidences of vitamin D deficiency is a prime factor driving growth of the sarcopenia treatment market. According to the U.S. National Library of Medicine, vitamin D deficiency is prevalent worldwide. The prevalence of Vitamin D deficiency ranged from 40% to 99%, with most of the studies reporting a prevalence of 80%–90%. It was prevalent in all the age groups and high-risk groups alike. Increasing consumption of nutrition and dietary supplement in order to cope up with the condition is again fostering growth of the market. Rise is aging population is another key factor increasing prevalence of sarcopenia which in turn accelerating market growth.
North America is expected to witness significant growth over the forecast period owing to the increasing aging population in the region. According to U.S. Census Bureau, there were 40.3M U.S. residents 65 years and older in the 2010 Census and 54.1M in the July 1, 2019, population estimates.
Key Developments:
- In January 2022, MyMD Pharmaceuticals, Inc. a pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. Patent and Trademark Office (USPTO) awarded to the company U.S. Patent 11,219,620 B2, titled “Method of Treating Sarcopenia.”
- In February 2021, MYOS CORP ("MYOS" or the "Company"), a research-based advanced nutrition company announced that it has been granted United States Patent #10,925,904 by the United States Patent and Trademark Office (USPTO) for improving skeletal muscle protein synthetic rate in older mammals through the administration of proprietary nutritional compositions such as MYOS' advanced nutrition product, Fortetropin
- In October 2021, Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its chronic sarcopenia treatment for healthy aging
- In August 2021, Biophytis SA announces the top line results of the SARA-INT phase 2 clinical study with Sarconeos (BIO101) in Sarcopenia.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Sarcopenia Treatment Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Sarcopenia Treatment Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Abbott laboratories, Inc.
- American Way (Amway) Corporation
- Bayer AG
- GlaxoSmithKline plc.
- Nestle S.A.
- Pfizer, Inc.
- Novartis AG
- Sanofi, Inc.
- Zydus Cadila, Ltd
- F-Hoffmann La-Roche
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Sarcopenia Treatment Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Protein Supplements
- Vitamin B12 Supplements
- Vitamin D & Calcium Supplements
- Others
By Applications, the market is segmented into:
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Online Pharmacies
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sarcopenia Treatment Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Sarcopenia Treatment Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Sarcopenia Treatment Market
1.6.1 How the Covid-19 is Affecting the Sarcopenia Treatment Market
1.6.1.1 Sarcopenia Treatment Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Sarcopenia Treatment Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Sarcopenia Treatment Market Perspective (2015-2028)
2.2 Sarcopenia Treatment Market Growth Trends by Regions
2.2.1 Sarcopenia Treatment Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Sarcopenia Treatment Market Historic Market Share by Regions (2015-2021)
2.2.3 Sarcopenia Treatment Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Sarcopenia Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Sarcopenia Treatment Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sarcopenia Treatment Market Players by Market Size
3.1.1 Global Top Sarcopenia Treatment Market Players by Revenue (2015-2021)
3.1.2 Global Sarcopenia Treatment Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Sarcopenia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sarcopenia Treatment Market Concentration Ratio
3.2.1 Global Sarcopenia Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sarcopenia Treatment Market Revenue in 2019
3.3 Sarcopenia Treatment Market Key Players Head office and Area Served
3.4 Key Players Sarcopenia Treatment Market Product Solution and Service
3.5 Date of entering into Sarcopenia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Sarcopenia Treatment Market Historic Market Size by Type (2015-2021)
4.2 Global Sarcopenia Treatment Market Forecasted Market Size by Type (2021-2028)
5 Sarcopenia Treatment Market Breakdown Data by Application (2015-2028)
5.1 Global Sarcopenia Treatment Market Size by Application (2015-2021)
5.2 Global Sarcopenia Treatment Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Sarcopenia Treatment Market Size (2015-2021)
6.2 Sarcopenia Treatment Market Key Players in North America (2019-2021)
6.3 North America Sarcopenia Treatment Market Size by Type (2015-2021)
6.4 North America Sarcopenia Treatment Market Size by Application (2015-2021)
7 Europe
7.1 Europe Sarcopenia Treatment Market Size (2015-2021)
7.2 Sarcopenia Treatment Market Key Players in Europe (2019-2021)
7.3 Europe Sarcopenia Treatment Market Size by Type (2015-2021)
7.4 Europe Sarcopenia Treatment Market Size by Application (2015-2021)
8 China
8.1 China Sarcopenia Treatment Market Size (2015-2021)
8.2 Sarcopenia Treatment Market Key Players in China (2019-2021)
8.3 China Sarcopenia Treatment Market Size by Type (2015-2021)
8.4 China Sarcopenia Treatment Market Size by Application (2015-2021)
9 Japan
9.1 Japan Sarcopenia Treatment Market Size (2015-2021)
9.2 Sarcopenia Treatment Market Key Players in Japan (2019-2021)
9.3 Japan Sarcopenia Treatment Market Size by Type (2015-2021)
9.4 Japan Sarcopenia Treatment Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Sarcopenia Treatment Market Size (2015-2021)
10.2 Sarcopenia Treatment Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Sarcopenia Treatment Market Size by Type (2015-2021)
10.4 Southeast Asia Sarcopenia Treatment Market Size by Application (2015-2021)
11 India
11.1 India Sarcopenia Treatment Market Size (2015-2021)
11.2 Sarcopenia Treatment Market Key Players in India (2019-2021)
11.3 India Sarcopenia Treatment Market Size by Type (2015-2021)
11.4 India Sarcopenia Treatment Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Sarcopenia Treatment Market Size (2015-2021)
12.2 Sarcopenia Treatment Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Sarcopenia Treatment Market Size by Type (2015-2021)
12.4 Central & South America Sarcopenia Treatment Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Sarcopenia Treatment Market Introduction
13.4 Sarcopenia Treatment Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Sarcopenia Treatment Market Key Market Segments
Table 2. Key Players Covered: Ranking by Sarcopenia Treatment Market Revenue
Table 3. Ranking of Global Top Sarcopenia Treatment Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sarcopenia Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Sarcopenia Treatment Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Sarcopenia Treatment Market Players to Combat Covid-19 Impact
Table 10. Global Sarcopenia Treatment Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Sarcopenia Treatment Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Sarcopenia Treatment Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Sarcopenia Treatment Market Share by Regions (2015-2021)
Table 14. Global Sarcopenia Treatment Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Sarcopenia Treatment Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Sarcopenia Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Sarcopenia Treatment Market Players
Table 21. Global Sarcopenia Treatment Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Sarcopenia Treatment Market Share by Players (2015-2021)
Table 23. Global Top Sarcopenia Treatment Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sarcopenia Treatment Market as of 2019)
Table 24. Global Sarcopenia Treatment Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Sarcopenia Treatment Market Product Solution and Service
Table 27. Date of entering into Sarcopenia Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Sarcopenia Treatment Market Size by Type (2015-2021) (Million US$)
Table 30. Global Sarcopenia Treatment Market Size Share by Type (2015-2021)
Table 31. Global Sarcopenia Treatment Market Revenue Market Share by Type (2021-2028)
Table 31. Global Sarcopenia Treatment Market Size Share by Application (2015-2021)
Table 33. Global Sarcopenia Treatment Market Size by Application (2015-2021) (Million US$)
Table 34. Global Sarcopenia Treatment Market Size Share by Application (2021-2028)
Table 35. North America Key Players Sarcopenia Treatment Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Sarcopenia Treatment Market Share (2019-2021)
Table 37. North America Sarcopenia Treatment Market Size by Type (2015-2021) (Million US$)
Table 38. North America Sarcopenia Treatment Market Share by Type (2015-2021)
Table 39. North America Sarcopenia Treatment Market Size by Application (2015-2021) (Million US$)
Table 40. North America Sarcopenia Treatment Market Share by Application (2015-2021)
Table 41. Europe Key Players Sarcopenia Treatment Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Sarcopenia Treatment Market Share (2019-2021)
Table 43. Europe Sarcopenia Treatment Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Sarcopenia Treatment Market Share by Type (2015-2021)
Table 45. Europe Sarcopenia Treatment Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Sarcopenia Treatment Market Share by Application (2015-2021)
Table 47. China Key Players Sarcopenia Treatment Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Sarcopenia Treatment Market Share (2019-2021)
Table 49. China Sarcopenia Treatment Market Size by Type (2015-2021) (Million US$)
Table 50. China Sarcopenia Treatment Market Share by Type (2015-2021)
Table 51. China Sarcopenia Treatment Market Size by Application (2015-2021) (Million US$)
Table 52. China Sarcopenia Treatment Market Share by Application (2015-2021)
Table 53. Japan Key Players Sarcopenia Treatment Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Sarcopenia Treatment Market Share (2019-2021)
Table 55. Japan Sarcopenia Treatment Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Sarcopenia Treatment Market Share by Type (2015-2021)
Table 57. Japan Sarcopenia Treatment Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Sarcopenia Treatment Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Sarcopenia Treatment Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Sarcopenia Treatment Market Share (2019-2021)
Table 61. Southeast Asia Sarcopenia Treatment Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Sarcopenia Treatment Market Share by Type (2015-2021)
Table 63. Southeast Asia Sarcopenia Treatment Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Sarcopenia Treatment Market Share by Application (2015-2021)
Table 65. India Key Players Sarcopenia Treatment Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Sarcopenia Treatment Market Share (2019-2021)
Table 67. India Sarcopenia Treatment Market Size by Type (2015-2021) (Million US$)
Table 68. India Sarcopenia Treatment Market Share by Type (2015-2021)
Table 69. India Sarcopenia Treatment Market Size by Application (2015-2021) (Million US$)
Table 70. India Sarcopenia Treatment Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Sarcopenia Treatment Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Sarcopenia Treatment Market Share (2019-2021)
Table 73. Central & South America Sarcopenia Treatment Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Sarcopenia Treatment Market Share by Type (2015-2021)
Table 75. Central & South America Sarcopenia Treatment Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Sarcopenia Treatment Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Sarcopenia Treatment Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Sarcopenia Treatment Market Share by Type: 2021 VS 2028
Figure 2. Global Sarcopenia Treatment Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Sarcopenia Treatment Market Report Years Considered
Figure 8. Global Sarcopenia Treatment Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Sarcopenia Treatment Market Share by Regions: 2021 VS 2028
Figure 10. Global Sarcopenia Treatment Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Sarcopenia Treatment Market Share by Players in 2019
Figure 13. Global Top Sarcopenia Treatment Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Sarcopenia Treatment Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Sarcopenia Treatment Market Revenue in 2019
Figure 15. North America Sarcopenia Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Sarcopenia Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Sarcopenia Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Sarcopenia Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Sarcopenia Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Sarcopenia Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Sarcopenia Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
